Hemp

GettyImages - CBD and AI / PrathanChorruangsak

CBD alliance to benefit from AI technology

By Olivia Haslam

The Association for the Cannabinoid Industry (ACI) and the Centre for Medicinal Cannabis (CMC) have formed a strategic partnership with Chem ID Ltd, a provider of chemical data standardisation, validation, and traceability solutions.

Getty images / skynesher

CBD in 2022: A year in review

By Danielle Masterson

We’re five years in, so what does the CBD industry look like now and what can we expect in 2023? We spoke with several CBD experts who walked us through the highs and lows of 2022.

©Getty Images - David Trood

Upcoming webinar to examine tumultuous CBD market

By Hank Schultz

Demand for CBD ingredients remains high and innovation continues apace even as the regulatory uncertainty of the category persists. A panel of influential speakers will delve into these and other questions in an upcoming webinar hosted by NutraIngredients-USA.

NutraCast: The fight to make cannabinoid therapy mainstream

NutraCast: The fight to make cannabinoid therapy mainstream

By Danielle Masterson

Through research, education, and grants, Realm of Caring is helping those in need of more information about cannabinoid therapies. The non-profit seeks to facilitate and encourage the mainstream acceptance of plant-powered therapies and serve healthcare...

NutraCast: Turning to CBD for mental health

NutraCast: Turning to CBD for mental health

By Danielle Masterson

Between Covid-19, supply chain issues and inflation, life is taking a serious toll on mental health. But more and more people are looking for ways to address mental health without a prescription.

HempRise introduces 5% CBD nanoemulsion

HempRise introduces 5% CBD nanoemulsion

By Danielle Masterson

The vertically-integrated supplier of hemp extracts and cannabinoid ingredients recently introduced HempNANO, its new concentrated nanoemulsion for water soluble applications.

© Getty Images

Study: Many CBD products would trigger doping bans

By Shane Starling

Almost a third of 23 tested CBD products contained traces of banned cannabinoids at levels that would have provoked doping infringements, according to a just-published study.

NutraCast: Exploring cannabis terpenes for pain management

NutraCast: Exploring cannabis terpenes for pain management

By Danielle Masterson

As the stigma surrounding cannabinoids fades, hemp-derived supplements are gaining traction as popular applications for pain management. New research from the University of Arizona Health Sciences in the Comprehensive Pain and Addiction Center have found...

©Getty Images - David Trood

FDA slams Delta-8 THC sellers over claims

By Hank Schultz

FDA came down hard on purveyors of Delta-8 THC and CBD products that were making disease claims on the substances. The Agency also reiterated the reasons it believes Delta-8 is not a suitable ingredient for products marketed as supplements.

© Handatko / Getty Images

CV Sciences reports 18% revenue drop for ‘challenging’ 2021

By Stephen Daniells

San Diego-based CV Sciences, one of the bell-weather companies in the hemp and CBD space, has reported a decline in revenues for the past financial year, but new initiatives have positioned the company for long-term growth, says its CEO.

Factoring CBD into the athletic equation

Factoring CBD into the athletic equation

By Danielle Masterson

This year’s Sports & Active Nutrition Summit event launched with a focus on CBD in sports nutrition. While CBD/hemp products are still in a federal regulatory gray area, that hasn’t stopped product developers from flooding the market with new offerings....

©Getty Images - Nastco

USP commentary sounds safety, quality alarm on delta-8 THC

By Hank Schultz

The United States Pharmacopeia (USP) has published a commentary raising potential safety and quality control concerns about the delta-8 THC products flooding the market. The document also raised issues with other cannabinoids that are being isolated...

© Aleksandr_Kravtsov / Getty Images

CV Sciences’ Q2 revenue rebounds after challenging Q1

By Stephen Daniells

CBD products manufacturer CV Sciences has recorded quarter-on-quarter increases in revenue, with increasing retail distribution and a “strong” innovation pipeline leading to bullish predictions for the rest of 2022.

NutraCast:Tracking CBD experiences in real-time with Releaf App

NutraCast:Tracking CBD experiences in real-time with Releaf App

By Danielle Masterson

More and more companies are using apps to gain insights on their respective industries. With the right data inputs, technology can improve decision making and help company leaders zero in on trends. The Releaf App is one such application that individuals...

AHPA's McGuffin on DSHEA 2.0, CBD's path forward, and more

AHPA's McGuffin on DSHEA 2.0, CBD's path forward, and more

By Stephen Daniells

While AHPA supports H.R.841, the association wishes FDA “would do its job and establish a legal pathway [for hemp and CBD], but they haven’t,” said Michael McGuffin. “Something needs to happen.”

CRN’s Mister on the best solution for CBD, DSHEA 2.0, and more

CRN’s Mister on the best solution for CBD, DSHEA 2.0, and more

By Stephen Daniells

The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act represents ‘the best way’ to deal with the hemp-CBD issue for dietary supplements, says CRN’s Steve Mister, and once that’s clarified then the FDA and industry can address...

Getty Images / 24K-Production

FDA yanks pending CBD enforcement proposal

By Danielle Masterson

The White House Office of Management and Budget pulled six FDA guidances and rules from its review, including the proposal "Cannabidiol Enforcement Policy; Draft Guidance for Industry" — handing the CBD industry yet another setback.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All